Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer

Author: Beer Tomasz   Javle Milind   Ryan Christopher   Garzotto Mark   Lam Gilbert   Wong Alvin   Henner W.   Johnson Candace   Trump Donald  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.59, Iss.5, 2007-04, pp. : 581-587

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content